Related references
Note: Only part of the references are listed.LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain
Francesca Boldrin et al.
BMC MICROBIOLOGY (2022)
Taming the Devil: Antimicrobial Peptides for Safer TB Therapeutics
Krishna Jadhav et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2022)
Advances in Nanostructures for Antimicrobial Therapy
Josef Jampilek et al.
MATERIALS (2022)
In the Thick of It: Formation of the Tuberculous Granuloma and Its Effects on Host and Therapeutic Responses
Mark R. Cronan
FRONTIERS IN IMMUNOLOGY (2022)
Antimicrobial Peptides: From Design to Clinical Application
Chunye Zhang et al.
ANTIBIOTICS-BASEL (2022)
An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis
Kiel Hards et al.
COMMUNICATIONS BIOLOGY (2022)
Plant Antimicrobial Peptides (PAMPs): Features, Applications, Production, Expression, and Challenges
Olalekan Olanrewaju Bakare et al.
MOLECULES (2022)
Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
Matthew B. B. McNeil et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Anti-persister and Anti-biofilm Activity of Self-Assembled Antimicrobial Peptoid Ellipsoidal Micelles
Jennifer S. Lin et al.
ACS INFECTIOUS DISEASES (2022)
Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response
Avinash Khadela et al.
VACCINES (2022)
Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications
Jasminka Talapko et al.
ANTIBIOTICS-BASEL (2022)
Engineering Approaches for the Development of Antimicrobial Peptide-Based Antibiotics
Su-Jin Kang et al.
ANTIBIOTICS-BASEL (2022)
Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A Review
Kanchan Mehta et al.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS (2022)
Drug Delivery Systems for the Oral Administration of Antimicrobial Peptides: Promising Tools to Treat Infectious Diseases
Caroline Deshayes et al.
FRONTIERS IN MEDICAL TECHNOLOGY (2022)
Antibacterial and antibiofilm potential of silver nanoparticles against antibiotic-sensitive and multidrug-resistant Pseudomonas aeruginosa strains
Davi de Lacerda Coriolano et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2021)
Antimicrobial activity of synthetic antimicrobial peptides loaded in poly-ε-caprolactone nanoparticles against mycobacteria and their functional synergy with rifampicin
Ankur Sharma et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Beneficial Impacts of Incorporating the Non-Natural Amino Acid Azulenyl-Alanine into the Trp-Rich Antimicrobial Peptide buCATHL4B
Areetha R. D'Souza et al.
BIOMOLECULES (2021)
Synergistic and On-Demand Release of Ag-AMPs Loaded on Porous Silicon Nanocarriers for Antibacteria and Wound Healing
Yao Jin et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Can Immobilized Artificial Membrane Chromatography Support the Characterization of Antimicrobial Peptide Origin Derivatives?
Krzesimir Ciura et al.
ANTIBIOTICS-BASEL (2021)
Phospholipid translocation captured in a bifunctional membrane protein MprF
Danfeng Song et al.
NATURE COMMUNICATIONS (2021)
Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review
Gabriel S. Oliveira et al.
PHARMACEUTICALS (2021)
Anti-mycobacterial activity evaluation of designed peptides: cryptic and database filtering based approach
Sneha Raj et al.
ARCHIVES OF MICROBIOLOGY (2021)
Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?
Bruno Rivas-Santiago et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2021)
Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular Mycobacterium tuberculosis
Reiner Noschka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Silver Nanoparticles and Their Antibacterial Applications
Tamara Bruna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Antimicrobial peptides in domestic animals and their applications in veterinary medicine
C. E. Valdez-Miramontes et al.
PEPTIDES (2021)
Nanostructured Antimicrobial Peptides: Crucial Steps of Overcoming the Bottleneck for Clinics
Zhanyi Yang et al.
FRONTIERS IN MICROBIOLOGY (2021)
The Antimicrobial Peptide Human β-Defensin-3 Accelerates Wound Healing by Promoting Angiogenesis, Cell Migration, and Proliferation Through the FGFR/JAK2/STAT3 Signaling Pathway
Miho Takahashi et al.
FRONTIERS IN IMMUNOLOGY (2021)
The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions
Bee Ha Gan et al.
CHEMICAL SOCIETY REVIEWS (2021)
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
Malak Pirtskhalava et al.
NUCLEIC ACIDS RESEARCH (2021)
The mycobacterial cell envelope - a moving target
Charles L. Dulberger et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Antimicrobial peptides conjugated with fatty acids on the side chain of D-amino acid promises antimicrobial potency against multidrug-resistant bacteria
Chao Zhong et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate
Paula Tucci et al.
PLOS ONE (2020)
Ultra-Short Antimicrobial Peptoids Show Propensity for Membrane Activity Against Multi-Drug Resistant Mycobacterium tuberculosis
Jasmeet Singh Khara et al.
FRONTIERS IN MICROBIOLOGY (2020)
A novel in silico antimicrobial peptide DP7 combats MDR Pseudomonas aeruginosa and related biofilm infections
Qi Yin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
EcDBS1R6: A novel cationic antimicrobial peptide derived from a signal peptide sequence
William F. Porto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2020)
Bacterial multi-solute transporters
Dirk J. Slotboom et al.
FEBS LETTERS (2020)
Transcriptome profiling and in silico detection of the antimicrobial peptides of red king crab Paralithodes camtschaticus
Igor A. Yakovlev et al.
SCIENTIFIC REPORTS (2020)
Super-Resolution Microscopy Reveals a Direct Interaction of IntracellularMycobacterium tuberculosiswith the Antimicrobial Peptide LL-37
Dhruva Deshpande et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
B1CTcu5: A frog-derived brevinin-1 peptide with anti-tuberculosis activity
Parvin Abraham et al.
PEPTIDES (2020)
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Yuchen Huan et al.
FRONTIERS IN MICROBIOLOGY (2020)
Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria
Lucas Assoni et al.
FRONTIERS IN MICROBIOLOGY (2020)
Polysaccharide length affects mycobacterial cell shape and antibiotic susceptibility
Alexander M. Justen et al.
SCIENCE ADVANCES (2020)
Synergies with and Resistance to Membrane-Active Peptides
Adam Kmeck et al.
ANTIBIOTICS-BASEL (2020)
Modulation of the M. tuberculosis cell envelope between replicating and non-replicating persistent bacteria
Haley Stokas et al.
TUBERCULOSIS (2020)
New Putative Antimicrobial Candidates: In silico Design of Fish-Derived Antibacterial Peptide-Motifs
Hedmon Okella et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
The ATP-Binding Cassette (ABC) Transport Systems in Mycobacterium tuberculosis: Structure, Function, and Possible Targets for Therapeutics
Marcelo Cassio Barreto de Oliveira et al.
BIOLOGY-BASEL (2020)
Antimicrobial Peptide against Mycobacterium Tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis
Erika A. Pelaez Coyotl et al.
PHARMACEUTICS (2020)
D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics
Jianguang Lu et al.
FRONTIERS IN MICROBIOLOGY (2020)
Nanostructured antimicrobial peptides: The last push towards clinics
Jose Vicente Carratala et al.
BIOTECHNOLOGY ADVANCES (2020)
Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019)
Mohamed Abd El-Gawad El-Sayed Ahmed et al.
EMERGING MICROBES & INFECTIONS (2020)
Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli
Zhenlong Wang et al.
COMMUNICATIONS BIOLOGY (2020)
Mycobacteria and their sweet proteins: An overview of protein glycosylation and lipoglycosylation in M-tuberculosis
Carolina Mehaffy et al.
TUBERCULOSIS (2019)
Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex
Alemayehu Godana Birhanu et al.
SCIENTIFIC REPORTS (2019)
Distributions of Extracellular Peptidases Across Prokaryotic Genomes Reflect Phylogeny and Habitat
Trang T. H. Nguyen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Synthesis of New Cyclomarin Derivatives and Their Biological Evaluation towards Mycobacterium Tuberculosis and Plasmodium Falciparum
Alexander Kiefer et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
High-Resolution Structure of CIpC1-Rufomycin and Ligand Binding Studies Provide a Framework to Design and Optimize Anti-Tuberculosis Leads
Nina M. Wolf et al.
ACS INFECTIOUS DISEASES (2019)
Cationic Antimicrobial Peptides for Tuberculosis: A Mini-Review
Sara Silva et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2019)
A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity
Sutharsana Yathursan et al.
JOURNAL OF PEPTIDE SCIENCE (2019)
Nanosystems as Vehicles for the Delivery of Antimicrobial Peptides (AMPs)
Angela Martin-Serrano et al.
PHARMACEUTICS (2019)
Stapled Peptides-A Useful Improvement for Peptide-Based Drugs
Mattia Moiola et al.
MOLECULES (2019)
Design of a Helical-Stabilized, Cyclic, and Nontoxic Analogue of the Peptide Cm-p5 with Improved Antifungal Activity
Fidel E. Morales Vicente et al.
ACS OMEGA (2019)
In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates
Elena Portell-Buj et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
Antimicrobial Peptides: Recent Insights on Biotechnological Interventions and Future Perspectives
Rajeshwari Sinha et al.
PROTEIN AND PEPTIDE LETTERS (2019)
In Silico Identification of Antimicrobial Peptides in the Proteomes of Goat and Sheep Milk and Feta Cheese
Marios Tomazou et al.
PROTEOMES (2019)
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen
Arundhati Maitra et al.
FEMS MICROBIOLOGY REVIEWS (2019)
Synergy between Circular Bacteriocin AS-48 and Ethambutol against Mycobacterium tuberculosis
Clara Aguilar-Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Cell envelope lipids in the pathophysiology of Mycobacterium tuberculosis
Parul Singh et al.
FUTURE MICROBIOLOGY (2018)
Antimicrobial peptides as an alternative to anti-tuberculosis drugs
Manaf AlMatar et al.
PHARMACOLOGICAL RESEARCH (2018)
RNase 7 but not psoriasin nor sPLA2-IIA associates with Mycobacterium tuberculosis during airway epithelial cell infection
Flor Torres-Juarez et al.
PATHOGENS AND DISEASE (2018)
Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics
Axel Hollmann et al.
FRONTIERS IN CHEMISTRY (2018)
Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence
Ciamak Ghazaei
JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2018)
A novel derivative of the fungal antimicrobial peptide plectasin is active against Mycobacterium tuberculosis
Erik Tenland et al.
TUBERCULOSIS (2018)
Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis
Akiho Yagi et al.
JOURNAL OF ANTIBIOTICS (2017)
Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberclosis
Shashank Gupta et al.
JOURNAL OF PATHOLOGY (2017)
Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are Acetylated
Alemayehu Godana Birhanu et al.
JOURNAL OF PROTEOME RESEARCH (2017)
lysX gene is differentially expressed among Mycobacterium tuberculosis strains with different levels of virulence
Alejandra Montoya-Rosales et al.
TUBERCULOSIS (2017)
Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane
Laura Chiaradia et al.
SCIENTIFIC REPORTS (2017)
Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design
Gurdyal Singh et al.
CURRENT DRUG TARGETS (2017)
Bacterial aminoacyl phospholipids - Biosynthesis and role in basic cellular processes and pathogenicity
Christoph Slavetinsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Heterogeneity in tuberculosis
Anthony M. Cadena et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Novel synthetic analogues of avian β-defensin-12: the role of charge, hydrophobicity, and disulfide bridges in biological functions
Ming Yang et al.
BMC MICROBIOLOGY (2017)
Progress in Self-Assembling Peptide-Based Nanomaterials for Biomedical Applications
Cui-Yun Yu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Total Synthesis of Cyclomarin A, a Marine Cycloheptapeptide with Anti-Tuberculosis and Anti-Malaria Activity
Philipp Barbie et al.
ORGANIC LETTERS (2016)
Interaction between antimicrobial peptides and mycobacteria
Thomas Gutsmann
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection model
Akhilesh Rai et al.
BIOMATERIALS (2016)
Antimicrobial peptides as novel anti-tuberculosis therapeutics
Joao P. Silva et al.
BIOTECHNOLOGY ADVANCES (2016)
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
D. I. Andersson et al.
DRUG RESISTANCE UPDATES (2016)
Assembling of the Mycobacterium tuberculosis Cell Wall Core
Anna E. Grzegorzewicz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment
Joao P. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2016)
The proteome targets of intracellular targeting antimicrobial peptides
Pramod Shah et al.
PROTEOMICS (2016)
The role of epigenetics in tuberculosis infection
Maruthai Kathirvel et al.
EPIGENOMICS (2016)
Antimicrobial Peptides : An Emerging Category of Therapeutic Agents
Margit Mahlapuu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Suppression of autophagy and antigen presentation by Mycobacterium tuberculosis PE_PGRS47
Neeraj K. Saini et al.
NATURE MICROBIOLOGY (2016)
Design of an α-helical antimicrobial peptide with improved cell-selective and potent anti-biofilm activity
Shi-Kun Zhang et al.
SCIENTIFIC REPORTS (2016)
Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination
Helena Polena et al.
SCIENTIFIC REPORTS (2016)
Interaction of antimicrobial peptide with mycolyl transferase in Mycobacterium tuberculosis
Devjani I. Banerjee et al.
INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2016)
Anti-Mycobacterial Peptides: From Human to Phage
Tieshan Teng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Cell Penetrating Synthetic Antimicrobial Peptides (SAMPs) Exhibiting Potent and Selective Killing of Mycobacterium by Targeting Its DNA
Aashish Sharma et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Prophylactic potential of defensins and L-isoleucine in tuberculosis household contacts: an experimental model
Bruno Rivas-Santiago et al.
IMMUNOTHERAPY (2015)
Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity
Georgios Daletos et al.
JOURNAL OF NATURAL PRODUCTS (2015)
A new antibiotic kills pathogens without detectable resistance
Losee L. Ling et al.
NATURE (2015)
Evaluation of the antibacterial and antibiofilm activities of novel CRAMP-vancomycin conjugates with diverse linkers
Nigam M. Mishra et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2015)
Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity
Santos Ramirez-Carreto et al.
PEPTIDES (2015)
The Cyclic Peptide Ecumicin Targeting ClpC1 Is Active against Mycobacterium tuberculosis In Vivo
Wei Gao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin
Jasmeet S. Khara et al.
BIOMATERIALS (2014)
A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response
Sachin Kumar Samuchiwal et al.
BMC INFECTIOUS DISEASES (2014)
Host Evasion and Exploitation Schemes of Mycobacterium tuberculosis
C. J. Cambier et al.
CELL (2014)
Lassomycin, a Ribosomally Synthesized Cyclic Peptide, Kills Mycobacterium tuberculosis by Targeting the ATP-Dependent Protease ClpC1P1P2
Ekaterina Gavrish et al.
CHEMISTRY & BIOLOGY (2014)
Early clearance of Mycobacterium tuberculosis: a new frontier in prevention
Ayesha J. Verrall et al.
IMMUNOLOGY (2014)
Wollamides: Antimycobacterial Cyclic Hexapeptides from an Australian Soil Streptomyces
Zeinab G. Khalil et al.
ORGANIC LETTERS (2014)
Discovery and Characterization of the Tuberculosis Drug Lead Ecumicin
Wei Gao et al.
ORGANIC LETTERS (2014)
Characterization of Antibacterial and Hemolytic Activity of Synthetic Pandinin 2 Variants and Their Inhibition against Mycobacterium tuberculosis
Alexis Rodriguez et al.
PLOS ONE (2014)
Cationic amphipathic D-enantiomeric antimicrobial peptides with in vitro and ex vivo activity against drug-resistant Mycobacterium tuberculosis
Yun Lan et al.
TUBERCULOSIS (2014)
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Abiola O. Olaitan et al.
FRONTIERS IN MICROBIOLOGY (2014)
Recent developments in protein and peptide parenteral delivery approaches
Ashaben Patel et al.
THERAPEUTIC DELIVERY (2014)
Targeting Mycobacterium tuberculosis and Other Microbial Pathogens Using Improved Synthetic Antibacterial Peptides
Santiago Ramon-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7
David Pulido et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Cathelicidin LL-37 Induces Angiogenesis via PGE2-EP3 Signaling in Endothelial Cells, In Vivo Inhibition by Aspirin
M. Dolores Salvado et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Peptide Design for Antimicrobial and Immunomodulatory Applications
Evan F. Haney et al.
BIOPOLYMERS (2013)
Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis
Bruno Rivas-Santiago et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
P4 ATPases: Flippases in Health and Disease
Vincent A. van der Mark et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Structural Basis of Mycobacterial Inhibition by Cyclomarin A
Dileep Vasudevan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CURRENT CONCEPTS Tuberculosis
Alimuddin Zumla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models
Bruno Rivas-Santiago et al.
PLOS ONE (2013)
Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis
Ligia Corrales-Garcia et al.
PROTEIN EXPRESSION AND PURIFICATION (2013)
Structural and Functional Characterization of Mycobactericidal Ubiquitin-Derived Peptides in Model and Bacterial Membranes
Marie H. Foss et al.
BIOCHEMISTRY (2012)
Synthesis and antimycobacterial activity of calpinactam derivatives
Kenichiro Nagai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms
Wen-Chi Chiang et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)
Hypoxia Triggers the Expression of Human β Defensin 2 and Antimicrobial Activity against Mycobacterium tuberculosis in Human Macrophages
Daniel Nickel et al.
JOURNAL OF IMMUNOLOGY (2012)
Cyclic AMP regulation of protein lysine acetylation in Mycobacterium tuberculosis
Ho Jun Lee et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Predicting antimicrobial peptides from eukaryotic genomes: In silico strategies to develop antibiotics
Andre C. Amaral et al.
PEPTIDES (2012)
The Natural Product Cyclomarin Kills Mycobacterium Tuberculosis by Targeting the ClpC1 Subunit of the Caseinolytic Protease
Esther K. Schmitt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Molecular Basis for the Selectivity of Antituberculosis Compounds Capreomycin and Viomycin
Rashid Akbergenov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis
Rinki Kapoor et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Action-Mechanism of Trichoderin A, an Anti-dormant Mycobacterial Aminolipopeptide from Marine Sponge-Derived Trichoderma sp.
Patamaporn Pruksakorn et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
Peptoid Origins
Ronald N. Zuckermann
BIOPOLYMERS (2011)
Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages
Avinash Sonawane et al.
CELLULAR MICROBIOLOGY (2011)
Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis
C. E. Rivas-Santiago et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Identification of a Genetic Locus Responsible for Antimicrobial Peptide Resistance in Clostridium difficile
Shonna M. McBride et al.
INFECTION AND IMMUNITY (2011)
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
Julian G. Hurdle et al.
NATURE REVIEWS MICROBIOLOGY (2011)
Antimicrobial peptide-modified liposomes for bacteria targeted delivery of temoporfin in photodynamic antimicrobial chemotherapy
Kewei Yang et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2011)
Anti-Tuberculosis Activity of alpha-Helical Antimicrobial Peptides: De Novo Designed L- and D-Enantiomers Versus L- and D-LL37
Ziqing Jiang et al.
PROTEIN AND PEPTIDE LETTERS (2011)
Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin
Fatoumata B. Sow et al.
TUBERCULOSIS (2011)
Describing the Mechanism of Antimicrobial Peptide Action with the Interfacial Activity Model
William C. Wimley
ACS CHEMICAL BIOLOGY (2010)
The ABC Transporter AnrAB Contributes to the Innate Resistance of Listeria monocytogenes to Nisin, Bacitracin, and Various β-Lactam Antibiotics
Barry Collins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Callyaerins A-F and H, new cytotoxic cyclic peptides from the Indonesian marine sponge Callyspongia aerizusa
Sabrin R. M. Ibrahim et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Trichoderins, novel aminolipopeptides from a marine sponge-derived Trichoderma sp., are active against dormant mycobacteria
Patamaporn Pruksakorn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis
J. Castaneda-Delgado et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes
F. -Xabier Contreras et al.
FEBS LETTERS (2010)
Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria
James Carroll et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905
Nobuhiro Koyama et al.
JOURNAL OF ANTIBIOTICS (2010)
cAMP-regulated Protein Lysine Acetylases in Mycobacteria
Subhalaxmi Nambi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome
Robin E. Stanley et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Staphylococcus aureus Mutant Screen Reveals Interaction of the Human Antimicrobial Peptide Dermcidin with Membrane Phospholipids
Min Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria
Kah Wee Koh et al.
MOLECULAR IMMUNOLOGY (2009)
Decreased outer membrane permeability protects mycobacteria from killing by ubiquitin-derived peptides
Georgiana E. Purdy et al.
MOLECULAR MICROBIOLOGY (2009)
The Two-Domain LysX Protein of Mycobacterium tuberculosis Is Required for Production of Lysinylated Phosphatidylglycerol and Resistance to Cationic Antimicrobial Peptides
Erin Maloney et al.
PLOS PATHOGENS (2009)
Antimicrobial effects of H4-(86-100), histogranin and related compounds - possible involvement of DNA gyrase
Simon Lemaire et al.
FEBS JOURNAL (2008)
Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells
Bruno Rivas-Santiago et al.
INFECTION AND IMMUNITY (2008)
Resistance to bacitracin in Bacillus subtilis:: Unexpected requirement of the BceAB ABC transporter in the control of expression of its own structural genes
Remi Bernard et al.
JOURNAL OF BACTERIOLOGY (2007)
Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis
Fatoumata B. Sow et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Study of the interaction of human Defensins with cell membrane models:: relationships between structure and biological activity
Marcos R. Lourenzoni et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2007)
Antimycobacterial activity of bacteriocins and their complexes with liposomes
Vasily Sosunov et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy
Sylvie Alonso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Human defensins: synthesis and structural properties
Marzena Pazgier et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Structure of a bacterial multidrug ABC transporter
Roger J. P. Dawson et al.
NATURE (2006)
β-defensin gene expression during the course of experimental tuberculosis infection
Bruno Rivas-Santiago et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens
Belinda H. Tan et al.
JOURNAL OF IMMUNOLOGY (2006)
Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype
Juan Carlos Toro et al.
MICROBES AND INFECTION (2006)
Human beta-defensins
M. Pazgier et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Conserved structure and function in the granulysin and NK-lysin peptide family
CMA Linde et al.
INFECTION AND IMMUNITY (2005)
Human β-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells
B Rivas-Santiago et al.
INFECTION AND IMMUNITY (2005)
Regulation of Mycobacterium tuberculosis cell envelope composition and virulence by intramembrane proteolysis
H Makinoshima et al.
NATURE (2005)
In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis
L Fattorini et al.
PEPTIDES (2004)
Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy
A Kalita et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Protein-mediated transbilayer movement of lipids in eukaryotes and prokaryotes: the relevance of ABC transporters
A Tannert et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2003)
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
PJ Brennan
TUBERCULOSIS (2003)
Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy
K Yu et al.
JOURNAL OF PEPTIDE RESEARCH (2002)
Intracellular targets of antibacterial peptides
M Cudic et al.
CURRENT DRUG TARGETS (2002)
Dermcidin: a novel human antibiotic peptide secreted by sweat glands
B Schittek et al.
NATURE IMMUNOLOGY (2001)
DNA as the intracellular secondary target for antibacterial action of human neutrophil peptide-I against Mycobacterium tuberculosis H37Ra
S Sharma et al.
CURRENT MICROBIOLOGY (2001)
In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis
CMA Linde et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Antimycobacterial agent based on mRNA encoding human β-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis
KO Kisich et al.
INFECTION AND IMMUNITY (2001)
Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37RV:: in vitro and ex vivo study
S Sharma et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
Share Paper
